跳至主要内容
临床试验/NCT02946762
NCT02946762已完成不适用

Z 31501 - Treatment as Prevention (TasP) in Correctional Facilities in Zambia and South Africa

University of North Carolina, Chapel Hill1 个研究点 分布在 1 个国家目标入组 419 人开始时间: 2016年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
419
试验地点
1
主要终点
Proportion of inmates with HIV-infection who were assessed for and offered ART initiation under TasP/UTT

研究概览

简要总结

At correctional facilities in Zambia and South Africa, a cross-sectional study design will be used to characterize the full continuum of integrated HIV/TB care under Treatment as Prevention (TasP), and will enrich this approach by: 1) using individual-level cohort data for HIV-infected inmates to assess ART uptake under TasP/Universal Test and Treat (UTT), as well as 6-month virological suppression and retention in care for inmates initiating ART; and 2) mixed methods to identify health-system, corrections-related socio-cultural and individual-inmate barriers to and facilitators of TasP/UTT to refine TasP implementation; and 3) conducting a retrospective chart review using routine data from Ministry of Health registers to reconstruct an approximate HIV and TB cascade for all inmates (HIV-infected and HIV-uninfected) at 3 and 12 months into TasP/UTT implementation.

详细描述

Treatment as Prevention (TasP) offers promise to: (1) prevent HIV transmission among incarcerated populations; and (2) improve inmate health and tuberculosis control through provision of immediate ART using a "universal test and treat" (UTT) approach.

Increased uptake of routine HIV counseling and testing (HCT) services will be encouraged and currently available ART care will be augmented by offering immediate ART initiation to all HIV-infected inmates not already on ART (after screening for TB and kidney disease) regardless of CD4 count. In this way, the study will promote universal HCT and ART access.

Existing, routine service delivery platforms operated by the MOH and Zambia

Corrections Service will be strengthened in hopes of achieving the following:

  1. Universal HIV testing within 2 months of facility entry and annually for all current inmates
  2. Clear integration of TB screening and treatment within HIV care services
  3. Scaling-up inmate peer supporters and support groups to promote ART adherence
  4. Strengthened systems for providing integrated TB/HIV care in correctional settings
  5. Improved continuity of care for prisoners initiating ART

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Previously known or newly diagnosed HIV-infected inmates
  • Not on ART
  • No documented release date within 30 days of enrollment
  • Incarcerated in an adult correctional ward at one of the three study sites.

排除标准

  • 未提供

结局指标

主要结局

Proportion of inmates with HIV-infection who were assessed for and offered ART initiation under TasP/UTT

时间窗: 2 years

次要结局

  • Proportion of HIV-infected inmates with TB diagnosis who initiate anti-TB therapy under TasP/UTT(2 years)
  • Proportion of all HIV-infected inmates starting ART who are retained on ART among those who remain in the study facility(2 years)
  • Proportion of inmates on ART with an HIV RNA <40 c/mL at 12 months of ART(12 months)
  • Proportion of inmates on ART with an HIV RNA <40 c/mL at 6 months of ART(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

TasP in Correctional Facilities | 临床试验